Pharmacological Studies
HPR specializes in efficacy testing of therapeutics in cynomolgus macaque disease models.
We also provide pharmacological consultation for your research and development programs.
HPR's Primate Center and Central Research Facility are located in Hamamatsu, Japan.
Central Nervous System
-
Stroke
-
Photochemically-induced thrombosis (PIT)
-
Thromboembolic
-
Transient and permanent occlusion
-
-
Neurological disease
-
Parkinson's disease
-
Pain
-
Capsaicin-induced acute pain
-
Oxaliplatin-induced polyneuropathic pain
-
Postoperative pain
-
Visceral pain
-
Peripheral mononeuropathic pain
-
Osteoarthritis (OA)
Ophthalmology
-
Age-related macular degeneration
-
dry AMD and wet AMD
-
-
Glaucoma
Gastroenterology
-
Inflammatory bowel disease (IBD)
-
Visceral pain/Irritable bowel syndrome (IBS)
Other Therapeutic Areas
-
Cardiovascular disorders
-
Thrombosis
-
-
Reproductive diseases
-
Naturally-occuring endometriosis
-
-
Skin disorders
-
Pruritus
-
HPR Pharmacological Studies
Our Services
When it comes to designing a preclinical pharmacological study, a well thought out process-flow, appropriate selection of an animal model and well defined experimental endpoints are critical.
With HPR’s expertise in preclinical pharmacology, your study will be fully supported every step of the way.
Study Consultation
-
Study protocol design utilizing a NHP disease model
-
Study planning and execution
Disease Model Customization
-
Customization of existing models
-
New model development
Pharmacological Studies
-
Primary therapeutic areas:
Pain, Stroke, Endometriosis, OA, AMD, Glaucoma, IBD, Thrombosis, and Pruritus -
Model development in other therapeutic areas
NHP Housing
AAALAC-accredited nonhuman primate facility
Please contact us for more information concerning our NHP models and services.